AngioWaveNet vs qXR-CTR

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Angiowave Imaging
VS
by Qure.ai Technologies

AI Verdict

AngioWaveNet is designed to enhance fluoroscopic angiograms, improving vessel visualization during cardiac catheterization procedures. Conversely, qXR-CTR automates the measurement of the cardiothoracic ratio from chest X-rays to aid in assessing heart size. While both are FDA-cleared AI tools in the cardiology and radiology domains, they serve distinct purposes and operate on different imaging modalities.

Choose AngioWaveNet if…

Choose AngioWaveNet if your cardiac catheterization lab requires enhanced, real-time visualization of blood vessels and anatomical features during fluoroscopic angiograms. This tool is ideal for interventional cardiologists seeking to improve diagnostic accuracy and procedural guidance by leveraging AI-powered spatiotemporal enhancement within existing workflows.

View AngioWaveNet →

Choose qXR-CTR if…

Choose qXR-CTR if your facility needs an automated, rapid assessment of heart size from standard chest X-ray images. This tool is best suited for screening large populations or for initial diagnostic triage to quickly identify patients with an elevated cardiothoracic ratio, aiding in the early detection of potential heart failure risk.

View qXR-CTR →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature AngioWaveNet qXR-CTR
Pricing Pricing options include annual software licensing or subscription-based access, tailored to cath lab volume and hospital needs. custom packages are available. Contact for pricing
Deployment Cloud-based or on-premise/servers Cloud, on-premise, hybrid
FDA Status 1 AI-estimated 1 AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

qXR-CTR

While AngioWaveNet emphasizes minimal training and seamless integration into existing Cath lab workflows, qXR-CTR offers broader usability features. qXR-CTR provides multilingual UI and reporting, along with mobile and desktop access via its app, catering to a wider range of user preferences and access points.

Clinical Value

AngioWaveNet

Both tools are FDA-cleared and offer significant clinical benefits. AngioWaveNet directly enhances fluoroscopic angiograms for improved vessel visualization during cardiac catheterization, leading to faster procedural decision-making and increased confidence in complex cases. This real-time impact on interventional procedures provides a critical and immediate clinical advantage.

Pricing & Value

AngioWaveNet

AngioWaveNet offers more transparent pricing models, including annual software licensing or subscription-based access tailored to cath lab volume and hospital needs, with custom packages available. In contrast, qXR-CTR's pricing is not publicly disclosed, requiring direct contact for information, which makes upfront value assessment more challenging.

Enterprise Readiness

qXR-CTR

Both tools offer flexible deployment options (cloud, on-premise, hybrid) and are HIPAA compliant with FDA clearance. However, qXR-CTR explicitly lists numerous integration partners (e.g., GE Healthcare, Philips, Siemens) and details additional privacy features like BAA availability, consent management, and data minimization, indicating a more comprehensive enterprise-level approach.

Innovation

AngioWaveNet

AngioWaveNet's AI-powered Spatiotemporal Enhancement Processing (STEPu2122) is a novel application of deep learning to interpret motion, structure, and time-based image data, revealing vessel details not visible in unprocessed angiograms. This represents a significant innovation in enhancing real-time image quality in a field that has seen little innovation in decades.

Support & Docs

Tie

Neither the provided structured facts nor the web search results offer sufficient specific information regarding the quality or availability of support services and documentation for either AngioWaveNet or qXR-CTR. While both imply ease of integration and use, direct comparative details on support are absent.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature AngioWaveNet qXR-CTR
Name AngioWaveNet qXR-CTR
Company Angiowave Imaging Qure.ai Technologies
Primary Function Enhances fluoroscopic angiograms for improved vessel visualization in cardiac catheterization laboratories. Automates the measurement of the cardiothoracic ratio (CTR) from chest X-ray images.
Specific Use Case / Key Benefit Improved vessel visualization in fluoroscopic angiograms; compatible with any fluoroscopic angiography system (vendor-agnostic). Aids in the assessment of heart size and potential heart failure risk from chest X-rays.

Videos

Demos, reviews, and walkthroughs featuring AngioWaveNet and qXR-CTR.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

AngioWaveNet is designed to enhance fluoroscopic angiograms for improved vessel visualization in cardiac catheterization laboratories. qXR-CTR automates the measurement of the cardiothoracic ratio (CTR) from chest X-ray images, aiding in the assessment of heart size and potential heart failure risk.
AngioWaveNet integrates with existing Cath lab workflows and functions as a DICOM endpoint for imaging systems. qXR-CTR is an AI-powered software that automates a specific measurement from chest X-ray images, aiding in diagnostic assessment.
AngioWaveNet processes fluoroscopic angiograms, offering vendor-agnostic compatibility with any fluoroscopic angiography system. qXR-CTR specifically analyzes chest X-ray images to perform its automated measurements.
AI Tool Finder
AI-powered search. Results may not be comprehensive.